Bar

Bar

Our Approach
Focus & Pipeline
About Us
News &
Resources
- News
- Presentations and Publications
Join Us

News

Press Releases

August 26, 2020

Vor Biopharma Appoints John King as Chief Commercial Officer

July 30, 2020

Vor Biopharma Appoints David Lubner to its Board of Directors

July 16, 2020

Vor Biopharma Appoints Daniella Beckman to its Board of Directors

July 14, 2020

Vor Biopharma Appoints Dr. Christopher Slapak as Chief Medical Officer

July 7, 2020

Vor Biopharma Closes $110 Million Series B Financing

May 26, 2020

Vor Biopharma Adds to Leadership Team with Appointment of Chief Financial Officer

Load More Posts

Media Coverage

July 22, 2019

“The Promise and Price of Cellular Therapies”

The New Yorker

June 5, 2019

“Meet the Man Who’s Taking On the Emperor of All Maladies: Cancer”

J&J Innovation

February 14, 2019

“Vor Biopharma raises $42M in Series A round to advance AML cell therapy toward clinic”

MedCity News

May 17, 2018

“Beyond B Cells: How Vor Biopharma’s Platform Could Eliminate On-Target Toxicity for CAR-Ts”

BioCentury

100 Cambridgepark Dr, Suite 400, Cambridge, MA 02140

P: 617-655-6580

Email

Contact Us
Privacy Policy
Terms of Use

© 2021 Vor Biopharma. All rights reserved.